Αποτελέσματα Αναζήτησης
26 Οκτ 2023 · Serious side effects of Adalat. Along with its needed effects, nifedipine (the active ingredient contained in Adalat) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
3 Μαΐ 2023 · What Are Side Effects of Adalat XL? Side effects of Adalat XL include: headache, anxiety, numbness and/or pins and needles sensation, confusion, fluid retention (edema), vasodilation, constipation, dizziness, fatigue, weakness/lethargy, nervousness, excessive muscle movement, palpitations, upset stomach, nausea, anxiety, indigestion, insomnia ...
Side effects can be mild or severe, temporary or permanent. The side effects listed below are not experienced by everyone who takes this medication. If you are concerned about side effects, discuss the risks and benefits of this medication with your doctor. The following side effects have been reported by at least 1% of people taking this ...
22 Μαρ 2024 · Before taking nifedipine, tell your doctor if you have kidney or liver disease, a blockage in your digestive tract (stomach or intestines), a history of stomach surgery, coronary artery disease, or congestive heart failure. If you need surgery, tell the surgeon ahead of time that you are using nifedipine.
8 Νοε 2013 · Serious side effects have been reported with nifedipine including: congestive heart failure (CHF). Tell your healthcare provider right away if you experience any of the following symptoms of CHF: sudden weight gain; worsening shortness of breath; increased swelling of your feet, legs, or abdomen; needing more pillows or sleeping in a recliner
1 Φεβ 2024 · Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
26 Μαρ 1992 · In 661 hypertensive patients treated in controlled trials with ADALAT XL, adverse effects were reported in 54.0% of patients and required discontinuation of therapy in 11.9% of patients. The majority of adverse effects reported occurred within the first three months of therapy.
